AI assistant
Sending…
CStone Pharmaceuticals — Director's Dealing 2022
Jun 13, 2022
50715_rns_2022-06-13_b759c870-6eef-4e19-8066-49802a880bf3.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [173 x 58] intentionally omitted <==
Public Disclosure Form
13 June 2022
Possible offer
Disclosure of dealings in the shares of Yankuang Energy Group Company Limited
The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:
| Party | Date | Description of relevant securities |
Description of products |
Nature of dealings |
Number of reference securities to which the derivatives relate |
Maturity date / closing out date |
Reference price |
Total amount paid / received |
Resultant balance (including those of any person with whom there is an agreement or understanding) |
|---|---|---|---|---|---|---|---|---|---|
| China International Capital Corporation Limited |
10 June 2022 | Derivatives | Other types of products |
Closing out of a derivative contract |
4,000 | 19 February 2025 |
$28.2000 | $112,800.0000 | 74,000 |
| Derivatives | Other types of products |
Closing out of a derivative contract |
6,000 | 22 May 2024 | $28.2000 | $169,200.0000 | 58,000 | ||
| Derivatives | Other types of products |
Closing out of a derivative contract |
4,000 | 19 February 2025 |
$28.2000 | $112,800.0000 | 74,000 |
==> picture [71 x 43] intentionally omitted <==
Public Disclosure Form
| Derivatives | Other types of products |
Closing out of a derivative contract |
6,000 | 22 May 2024 | $28.2000 | $169,200.0000 | 58,000 | ||
|---|---|---|---|---|---|---|---|---|---|
End
Note:
China International Capital Corporation Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.
More from CStone Pharmaceuticals
Transaction in Own Shares
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 7
Environmental & Social Information
2026
Apr 27
Annual Report
2026
Apr 27
Share Issue/Capital Change
2026
Apr 23
Share Issue/Capital Change
2026
Apr 22
Share Issue/Capital Change
2026
Apr 22
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 20